Boston Scientific BSX is slated to report first-quarter 2025 results on April 23, before market open. For first-quarter 2025, Boston Scientific projects adjusted earnings in the range of 66-68 cents ...

Boston Scientific will face more benign competition than previously feared when it comes to pulsed field ablation, according ...

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.

Needham raised its rating on Boston Scientific (NYSE:BSX) from Hold to Buy, setting a new price target of $113, citing ...

Needham has upgraded Boston Scientific to a Buy, setting a new $113 target based on strengthened growth potential and less ...